A preclinical platform of breast cancer PDX-derived cell lines as a tool for pharmacological screening and functional studies

被引：0
|
作者：
Cairo, Stefano [1 ]
Deas, Olivier [1 ]
Banis, Sophie [1 ]
Flosseau, Kathleen [1 ]
Le Ven, Enora [1 ]
Judde, Jean-Gabriel [1 ]
机构：
[1] XenTech, Evry, France
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS17-52
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A breast cancer PDX-derived cell lines preclinical platform as a tool for pharmacological screening and functional studies
    Flosseau, Kathleen
    Sinayen, Lea
    Le Ven, Enora
    Indersie, Emilie
    Morgado, Ester
    Pouyet, Laurent
    Romagne, Francois
    Deas, Olivier
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [2] A preclinical platform of PDX-derived cell lines as a tool for pharmacological screening and functional studies.
    Deas, Olivier
    Banis, Sophie
    Flosseau, Kathleen
    Sinayen, Lea
    Le Ven, Enora
    Judde, Jean-Gabriel
    Cairo, Stefano
    CANCER RESEARCH, 2021, 81 (13)
  • [3] PDX-derived cell line platform for pharmacological screening and functional studies
    Deas, Olivier
    Sinayen, Lea
    Indersie, Emilie
    Flosseau, Kathleen
    Banis, Sophie
    Le Ven, Enora
    Judde, Jean-Gabriel
    Cairo, Stefano
    CANCER RESEARCH, 2022, 82 (12)
  • [4] A preclinical platform of breast cancer PDX and derived cellular models as a tool for pharmacological screening and functional studies
    Nicolle, Delphine
    Gorce, Aurore
    Tavernier, Marie
    Marangoni, Elisabetta
    Decaudin, Didier
    Ginestier, Christophe
    Charafe-Jaufret, Emmanuelle
    Passildas, Judith
    Robin, Nina
    Clarke, Robert
    Corcuff, Erwan
    Joachim, Anais
    Malissen, Bernard
    Zarubica, Ana
    Luche, Herve
    Judde, Jean-Gabriel
    Deas, Olivier
    CANCER RESEARCH, 2023, 83 (07)
  • [5] A preclinical platform of prostate cancer PDX and derived cellular models as a tool for pharmacological screening and functional studies
    Indersie, Emilie
    Sinayen, Lea
    Bigot, Ludovic
    Mevel, Katell
    Gorse, Aurore
    Tavernier, Marie
    Le Ven, Enora
    Friboulet, Luc
    Farace, Francoise
    Morgado, Ester
    Pouyet, Laurent
    Loriot, Yohann
    Romagne, Francois
    Deas, Olivier
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Systematic genomic analysis of matched PDX, PDX-derived organoids (PDXO), and PDX-derived cell lines (PDXC)
    Xu, Xiaoxi
    Qian, Wubin
    Guo, Sheng
    Li, Henry Q.
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Proteomic analysis of conserved kinases between PDX tumors and corresponding PDX-derived cell lines
    Han, Airi
    Kim, Beom-Jun
    Chan, Doug W.
    Matsunuma, Ryoich
    Singh, Purba
    Ellis, Matthew James
    CANCER RESEARCH, 2018, 78 (04)
  • [8] Establishment of PDX model of oral cancer and PDX-derived cell lines, and usefulness of anti-HER2 antibody therapy
    Seki, Yuki
    Kariya, Ryusho
    Yoshida, Ryoji
    Kawahara, Kenta
    Hirayama, Masatoshi
    Takahashi, Nozomu
    Nakamoto, Masafumi
    Takeshita, Hisashi
    Okada, Seiji
    Nakayama, Hideki
    CANCER SCIENCE, 2024, 115 : 1074 - 1074
  • [9] Establishment of PDX-derived oral cancer cell lines and utility of anti-HER2 antibody therapy
    Seki, Yuki
    Kariya, Ryusyo
    Yoshida, Ryoji
    Kawahara, Kenta
    Hirayama, Masatoshi
    Nakamoto, Masafumi
    Hirosue, Akiyuki
    Okada, Seiji
    Nakayama, Hideki
    CANCER SCIENCE, 2025, 116 : 990 - 990
  • [10] A Comparison Between PDX Tumors and PDX-derived Cell Lines Highlights the Molecular Plasticity of Pancreatic Ductal Adenocarcinoma
    Baba, T.
    Mino-Kenudson, M.
    Lillemoe, K.
    Warshaw, A. L.
    Fernandez-del Castillo, C.
    Liss, A.
    PANCREAS, 2021, 50 (07) : 1046 - 1046
12345